Diving deep into the hemophilia market, Sanofi strikes an $11.6B Bioverativ buyout
Sanofi $SNY has finally bagged a multibillion-dollar biotech buyout.
In a statement early Monday the pharma giant said it has closed a deal to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
